Search research articles
Contact Us
Filters
Showing results (31-40 of 263) with videos related to
Page
of 27
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1985
Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans
M Eichelbaum, N M Woolhouse
Life Sciences
|
January 1, 1995
"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism
H K Kroemer, M Eichelbaum
Arzneimittel-Forschung
|
January 1, 1977
[Polymorphisms and deficient drug metabolism as triggers of toxic reactions (author's transl)]
H J Dengler, M Eichelbaum
Archiv Fur Toxikologie
|
January 1, 1971
[A specific and sensitive method for the determination of cyclohexylamine in biological fluids]
M Eichelbaum, H J Hengstmann
British Journal of Clinical Pharmacology
|
April 1, 1984
Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration
M Eichelbaum, G Mikus, B Vogelgesang
European Journal of Clinical Pharmacology
|
January 1, 1982
Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data
A Somogyi, M Eichelbaum, R Gugler
British Journal of Clinical Pharmacology
|
March 1, 1983
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine
M Eichelbaum, L Bertilsson, J Säwe
Life Sciences
|
May 12, 1986
A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver
B A Osikowska-Evers, M Eichelbaum
Drug Discovery Today
|
August 10, 2001
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy
U Brinkmann, I Roots, M Eichelbaum
Clinical Pharmacology and Therapeutics
|
July 1, 1985
Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism
H Echizen, B Vogelgesang, M Eichelbaum
Page
of 27
Search research articles
Search
Showing results (31-40 of 263) with videos related to
Sort By:
Page
of 27
European Journal of Clinical Pharmacology
|
January 1, 1985
Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans
M Eichelbaum, N M Woolhouse
Life Sciences
|
January 1, 1995
"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism
H K Kroemer, M Eichelbaum
Arzneimittel-Forschung
|
January 1, 1977
[Polymorphisms and deficient drug metabolism as triggers of toxic reactions (author's transl)]
H J Dengler, M Eichelbaum
Archiv Fur Toxikologie
|
January 1, 1971
[A specific and sensitive method for the determination of cyclohexylamine in biological fluids]
M Eichelbaum, H J Hengstmann
British Journal of Clinical Pharmacology
|
April 1, 1984
Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration
M Eichelbaum, G Mikus, B Vogelgesang
European Journal of Clinical Pharmacology
|
January 1, 1982
Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data
A Somogyi, M Eichelbaum, R Gugler
British Journal of Clinical Pharmacology
|
March 1, 1983
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine
M Eichelbaum, L Bertilsson, J Säwe
Life Sciences
|
May 12, 1986
A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver
B A Osikowska-Evers, M Eichelbaum
Drug Discovery Today
|
August 10, 2001
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy
U Brinkmann, I Roots, M Eichelbaum
Clinical Pharmacology and Therapeutics
|
July 1, 1985
Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism
H Echizen, B Vogelgesang, M Eichelbaum
Page
of 27